ACSL1 antibody
Principal name
ACSL1 antibody
Alternative names for ACSL1 antibody
FACL1, FACL2, LACS, LACS1, LACS2, Long-chain-fatty-acid--CoA ligase 1, Long-chain acyl-CoA synthetase 1, Long-chain acyl-CoA synthetase 2, Palmitoyl-CoA ligase 1, Palmitoyl-CoA ligase 2, Acyl-CoA synthetase 1, Long-chain fatty acid-CoA ligase 2
Ncbi ID
9606, NP_001986, NP_001986.2, NP_032007.2, NM_012820, NM_001995
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of ACSL1 antibody
ACSL1 encodes an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation.The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
General readings
Black PN and DiRusso CC. Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol. Mol. Biol. Rev. 2003; 67:454-72.
Coleman RA, Lewin TM, Van Horn CG, et al. Do acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 2002; 132:2123-6.
Clark H, Carling D, and Saggerson D. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. Eur. J. Biochem. 2004; 271:2215-24
Ellis JM, Mentock SM, DePetrillo MA, et al. Mouse cardiac acyl Coenzyme A synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy. Mol. Cell. Biol. 2011; 31:1252-62.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA309563 | ACSL1 antibody |
||||||
| Rabbit Polyclonal ACSL1 Antibody | |||||||
 |
Rabbit | Purified | Hu, Ms, Prim, Rt | WB |
0.1 ml /
€415.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA319649 | ACSL1 (Center) antibody |
||||||
| Rabbit Polyclonal ACSL1 Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms, Rt | E, WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR207852L2V | Lenti ORF particles, Acsl1 (GFP-tagged ORF) - Rat acyl-CoA synthetase long-chain family member 1 (Acsl1), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,460.00
|
|
| OriGene Technologies, Inc. | ||
| RR207852L1V | Lenti ORF particles, Acsl1 (Myc-DDK-tagged ORF) - Rat acyl-CoA synthetase long-chain family member 1 (Acsl1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,320.00
|
|
| OriGene Technologies, Inc. | ||